Blood test could replace risky liver biopsies for transplant patients
NCT ID NCT06153641
First seen Dec 29, 2025 · Last updated May 22, 2026 · Updated 18 times
Summary
This study looks at whether a blood test measuring a protein called CK-18 can detect when the body is rejecting a new liver. Currently, doctors use a needle biopsy, which is risky and invasive. About 70 liver transplant patients will give blood samples to see if CK-18 levels can reliably spot rejection and help adjust medications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER TRANSPLANT FAILURE AND REJECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
SSM Health Cardinal Glennon Children's Hospital & Saint Louis University Hospital (SSM Health- SLU Hospital)
St Louis, Missouri, 63104, United States
Conditions
Explore the condition pages connected to this study.